The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats

It is known that non-steroidal anti-inflammatory drugs increase cardiovascular (CV) morbidity and mortality. In this study, we examined whether a novel anti-inflammatory drug, bradykinin B1 receptor antagonist (FGY-1153) treatment could influence the development of hypertensive organ damages in spon...

Descripción completa

Detalles Bibliográficos
Autores principales: Deres, Laszlo, Eros, Krisztian, Horvath, Orsolya, Bencze, Noemi, Cseko, Csongor, Farkas, Sandor, Habon, Tamas, Toth, Kalman, Halmosi, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537226/
https://www.ncbi.nlm.nih.gov/pubmed/31178756
http://dx.doi.org/10.3389/fphys.2019.00624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537226/
https://www.ncbi.nlm.nih.gov/pubmed/31178756
http://dx.doi.org/10.3389/fphys.2019.00624

Ejemplares similares